These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 9164197

  • 1. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.
    Antman KH, Rowlings PA, Vaughan WP, Pelz CJ, Fay JW, Fields KK, Freytes CO, Gale RP, Hillner BE, Holland HK, Kennedy MJ, Klein JP, Lazarus HM, McCarthy PL, Saez R, Spitzer G, Stadtmauer EA, Williams SF, Wolff S, Sobocinski KA, Armitage JO, Horowitz MM.
    J Clin Oncol; 1997 May; 15(5):1870-9. PubMed ID: 9164197
    [Abstract] [Full Text] [Related]

  • 2. Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999.
    Pedrazzoli P, Ferrante P, Kulekci A, Schiavo R, De Giorgi U, Carminati O, Marangolo M, Demirer T, Siena S, Rosti G, European Group for Blood and Marrow Transplantation (EBMT), Solid Tumors Working Party.
    Bone Marrow Transplant; 2003 Sep; 32(5):489-94. PubMed ID: 12942095
    [Abstract] [Full Text] [Related]

  • 3. Autotransplants in men with breast cancer. ABMTR Breast Cancer Working Committee. Autologous Blood and Marrow Transplant Registry.
    McCarthy P, Hurd D, Rowlings P, Crump M, Gale R, Lazarus H, Vaughan W, Weinberger B, Wiemann M, Freytes C, Cirenza E, Antman K.
    Bone Marrow Transplant; 1999 Aug; 24(4):365-8. PubMed ID: 10467324
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer.
    Rowlings PA, Williams SF, Antman KH, Fields KK, Fay JW, Reed E, Pelz CJ, Klein JP, Sobocinski KA, Kennedy MJ, Freytes CO, McCarthy PL, Herzig RH, Stadtmauer EA, Lazarus HM, Pecora AL, Bitran JD, Wolff SN, Gale RP, Armitage JO, Vaughan WP, Spitzer G, Horowitz MM.
    JAMA; 1999 Oct 13; 282(14):1335-43. PubMed ID: 10527180
    [Abstract] [Full Text] [Related]

  • 6. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group.
    Stadtmauer EA, O'Neill A, Goldstein LJ, Crilley PA, Mangan KF, Ingle JN, Brodsky I, Martino S, Lazarus HM, Erban JK, Sickles C, Glick JH.
    N Engl J Med; 2000 Apr 13; 342(15):1069-76. PubMed ID: 10760307
    [Abstract] [Full Text] [Related]

  • 7. High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer.
    Demirer T, Buckner CD, Appelbaum FR, Clift R, Storb R, Myerson D, Lilleby K, Rowley S, Bensinger WI.
    Bone Marrow Transplant; 1996 May 13; 17(5):769-74. PubMed ID: 8733696
    [Abstract] [Full Text] [Related]

  • 8. Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer.
    Gale RP, Park RE, Dubois R, Bitran JD, Buzdar A, Hortobagyi G, Jones SE, Lazar GS, Spitzer G, Swain SM, Vaughn CB, Vogel CE, Martino S.
    Clin Transplant; 2000 Feb 13; 14(1):32-41. PubMed ID: 10693633
    [Abstract] [Full Text] [Related]

  • 9. Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.
    Lazarus HM, Rowlings PA, Zhang MJ, Vose JM, Armitage JO, Bierman PJ, Gajewski JL, Gale RP, Keating A, Klein JP, Miller CB, Phillips GL, Reece DE, Sobocinski KA, van Besien K, Horowitz MM.
    J Clin Oncol; 1999 Feb 13; 17(2):534-45. PubMed ID: 10080597
    [Abstract] [Full Text] [Related]

  • 10. High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience.
    Ayash LJ, Elias A, Wheeler C, Tepler I, Schwartz G, Schnipper L, Frei E, Antman K.
    J Hematother; 1993 Feb 13; 2(4):507-11. PubMed ID: 7916250
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.
    Alegre A, Díaz-Mediavilla J, San-Miguel J, Martínez R, García Laraña J, Sureda A, Lahuerta JJ, Morales D, Bladé J, Caballero D, De la Rubia J, Escudero A, Díez-Martín JL, Hernández-Navarro F, Rifón J, Odriozola J, Brunet S, De la Serna J, Besalduch J, Vidal MJ, Solano C, Leon A, Sánchez JJ, Martínez-Chamorro C, Fernández-Rañada JM.
    Bone Marrow Transplant; 1998 Jan 13; 21(2):133-40. PubMed ID: 9489629
    [Abstract] [Full Text] [Related]

  • 14. High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed.
    Vogl DT, Stadtmauer EA.
    Bone Marrow Transplant; 2006 Jun 13; 37(11):985-7. PubMed ID: 16708060
    [No Abstract] [Full Text] [Related]

  • 15. Phase II study of high-dose cyclophosphamide, etoposide, and carboplatin (CEC) followed by autologous hematopoietic stem cell rescue in women with metastatic or high-risk non-metastatic breast cancer: multivariate analysis of factors affecting survival and engraftment.
    Klumpp TR, Goldberg SL, Magdalinski AJ, Mangan KF.
    Bone Marrow Transplant; 1997 Aug 13; 20(4):273-81. PubMed ID: 9285541
    [Abstract] [Full Text] [Related]

  • 16. High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancer.
    Tallman MS, Rademaker AW, Jahnke L, Brown SG, Bauman A, Mangan C, Kelly C, Rubin H, Kies MS, Shaw J, Kiel K, Gordon LI, Gradishar WJ, Winter JN.
    Bone Marrow Transplant; 1997 Nov 13; 20(9):721-9. PubMed ID: 9384473
    [Abstract] [Full Text] [Related]

  • 17. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
    Lazarus HM, Loberiza FR, Zhang MJ, Armitage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes CO, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, Miller AM, Milone GA, Pavlovsky S, Reece DE, Rizzo JD, van Besien K, Vose JM, Horowitz MM.
    Bone Marrow Transplant; 2001 Feb 13; 27(4):387-96. PubMed ID: 11313668
    [Abstract] [Full Text] [Related]

  • 18. Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support.
    Bewick M, Chadderton T, Conlon M, Lafrenie R, Morris D, Stewart D, Glück S.
    Bone Marrow Transplant; 1999 Aug 13; 24(4):377-84. PubMed ID: 10467326
    [Abstract] [Full Text] [Related]

  • 19. High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience.
    Laport GF, Grad G, Grinblatt DL, Bitran JD, Williams SF.
    Bone Marrow Transplant; 1998 Jan 13; 21(2):127-32. PubMed ID: 9489628
    [Abstract] [Full Text] [Related]

  • 20. Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer.
    Rizzo JD, Williams S, Wu JT, Pecora AL, Lazarus HM, Bolwell B, Fields KK, Gale RP, Elfenbein G, Horowitz MM, Antman KH.
    Bone Marrow Transplant; 2003 Jul 13; 32(2):151-5. PubMed ID: 12838279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.